Nuvalent
Kristina Kehrig is an experienced professional in clinical operations with a career spanning over a decade in the pharmaceutical industry. Currently serving as Associate Director of Clinical Operations at Nuvalent, Inc. since July 2021, Kristina previously held the same title at Agenus for a short period. Prior to that, a significant role as Clinical Project Manager at BeiGene involved managing all aspects of a Phase II clinical trial alongside a large Phase III global trial. The career also includes positions as Senior Clinical Trial Associate at Infinity Pharmaceuticals and Clinical Trial Associate at Vertex Pharmaceuticals. Kristina holds a Bachelor's degree in Business from Saint Anselm College.
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.